Extendicare Inc. (TSE:EXE – Get Free Report) shares hit a new 52-week high during trading on Monday . The stock traded as high as C$10.60 and last traded at C$10.60, with a volume of 15813 shares trading hands. The stock had previously closed at C$10.38.
Wall Street Analyst Weigh In
A number of equities analysts have weighed in on the company. Royal Bank of Canada boosted their target price on Extendicare from C$8.50 to C$9.50 in a research report on Monday, August 19th. TD Securities boosted their target price on shares of Extendicare from C$9.50 to C$10.50 and gave the company a “hold” rating in a research note on Thursday, November 14th.
View Our Latest Research Report on EXE
Extendicare Stock Up 2.0 %
Extendicare Dividend Announcement
The firm also recently declared a monthly dividend, which was paid on Friday, November 15th. Stockholders of record on Thursday, October 31st were paid a dividend of $0.04 per share. This represents a $0.48 annualized dividend and a dividend yield of 4.55%. The ex-dividend date was Thursday, October 31st. Extendicare’s dividend payout ratio is presently 70.59%.
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Recommended Stories
- Five stocks we like better than Extendicare
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a Bond Market Holiday? How to Invest and Trade
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.